Association of lipid-lowering drug targets with risk of cutaneous melanoma: a mendelian randomization study

Abstract Background Melanoma proliferation is partly attributed to dysregulated lipid metabolism. The effectiveness of lipid-lowering drugs in combating cutaneous melanoma (CM) is a subject of ongoing debate in both in vitro and clinical studies. Method This study aims to evaluate the causal relatio...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Lusheng Miao, Taosheng Miao, Ying Zhang, Jin Hao
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2024-05-01
coleção:	BMC Cancer
Assuntos:	Cutaneous melanoma Lipid-lowering drugs Proprotein convertase subtilisin/Kexin type 9(PCSK9) Mendelian randomization
Acesso em linha:	https://doi.org/10.1186/s12885-024-12366-8
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!